Tagged: PSP

Peer Review: After the Review

September 14, 2021

In the fourth episode in the peer review series, Dr. Stefanie Hennig joins host Alaina Webster to walk you through what editors do with a review once it’s received. Stefanie, an Associate Editor for CPT: Pharmacometrics & Systems Pharmacology details her first steps upon receiving a review, how much a reviewer’s opinion influences her decision on a manuscript, and how she decides is reviewers are needed for a revised manuscript.

You can access PSP’s Reviewer Instructions and contact the editorial office to volunteer as a reviewer here.

PSPod

Peer Review: After the Review

00:00 / 11:53

Peer Review: What’s Not Helpful in a Review?

September 14, 2021

ClinPharmPod’s peer review series continues as host Alaina Webster is chats with Dr. Richard Peck about what to avoid when completing a review. They cover what’s too little and what’s too much in a review, the appropriate tone to strike when providing feedback, and the tricky topic that is unconscious bias.

You can access CPT’s Reviewer Instructions and contact the editorial office to volunteer as a reviewer here.

ClinPharmPod

Peer Review: What’s Not Helpful in a Review?

00:00 / 11:06

PDUFA VI: It Is Time to Unleash the Full Potential of Model-Informed Drug Development with Drs. Lokesh Jain, Larissa Wenning, and Nitin Mehrotra from Merck

April 29, 2019

On this episode of PSPod, Drs. Lokesh Jain, Larissa Wenning, and Nitin Mehrotra from Merck discuss the important role model-informed drug development (MIDD) will play in the successful implementation of PDUFA VI. This discussion is based on their Perspective article “PDUFA VI: It’s Time to Unleash the Full Potential of Model-Informed Drug Development” which published in the January 2019 issue of PSP. The article is available here.

PSPod

PDUFA VI: It Is Time to Unleash the Full Potential of Model-Informed Drug Development with Drs. Lokesh Jain, Larissa Wenning, and Nitin Mehrotra from Merck

00:00 / 19:45